Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The pharmaceutical industry is in perpetual pursuit of novel therapeutic agents, and the synthesis of these complex molecules relies heavily on versatile chemical intermediates. 1-Allyl-3-vinylimidazolium Bromide (CAS: 1072788-73-8) has emerged as a significant compound in this domain, offering unique reactive properties that are invaluable for pharmaceutical research and development (R&D). For procurement specialists and R&D scientists, understanding its role and how to source it reliably is key.
The Chemical Profile of 1-Allyl-3-vinylimidazolium Bromide
1-Allyl-3-vinylimidazolium Bromide is characterized by its imidazolium core, functionalized with both an allyl and a vinyl group. This dual functionality, coupled with its ionic nature, allows it to participate in a wide array of chemical reactions. As a solid with a high melting point (253°C), it offers convenience in handling and storage. Its molecular formula is C8H11BrN2, with a molecular weight of 215.09. For pharmaceutical synthesis, its purity, typically exceeding 97%, is a critical parameter that suppliers must consistently meet.
Role in Novel Drug Discovery and Synthesis
In pharmaceutical R&D, 1-Allyl-3-vinylimidazolium Bromide acts as a pivotal building block. The allyl and vinyl groups are susceptible to various transformations such as:
By utilizing this intermediate, pharmaceutical chemists can more efficiently synthesize novel compounds with potential therapeutic activities, accelerating the drug discovery pipeline. B2B buyers looking to purchase this compound for R&D purposes should prioritize suppliers who understand the stringent purity requirements of the pharmaceutical sector.
Ensuring Reliable Supply for R&D Projects
The continuity of R&D projects often hinges on the reliable availability of key reagents and intermediates. When sourcing 1-Allyl-3-vinylimidazolium Bromide, it's vital to partner with suppliers who can offer:
Manufacturers in China are often a preferred source due to their capacity and competitive pricing. Engaging with them early in the R&D phase can secure supply and pricing advantages.
Procurement Considerations for B2B Buyers
For B2B buyers in the pharmaceutical industry, procuring 1-Allyl-3-vinylimidazolium Bromide involves:
By adopting a diligent procurement strategy, pharmaceutical R&D teams can secure a dependable supply of 1-Allyl-3-vinylimidazolium Bromide, thereby fostering innovation and accelerating the development of new medicines.
In conclusion, 1-Allyl-3-vinylimidazolium Bromide is an indispensable intermediate for pharmaceutical R&D. Its unique chemical properties enable the synthesis of complex molecules crucial for drug discovery. By focusing on quality, reliability, and strategic sourcing, B2B buyers can effectively leverage this compound to drive advancements in the pharmaceutical sector.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
